Reid G. Adler serves as Executive at VistaGen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Reid G. Adler has executed 5 insider transactions totaling $51.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 30, 2025 involved receiving (via award) 7,541 shares valued at $12.8K.
Reid G. Adler currently holds 24,050 shares of VistaGen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reid G. Adler has been a net buyer of VTGN stock. They have purchased $51.0K and sold $0 worth of shares.
Reid G. Adler's most recent insider trade was on Jun 30, 2025, when they sold 7,541 shares at $1.70 per share.
Get notified when new Form 4 filings are submitted
| $2.96 |
| Discretionary |
| Dec 29, 2023 | VTGN | $287 | Award | 167 | $1.72 | Discretionary |
| Jun 30, 2023 | VTGN | $266 | Award | 167 | $1.59 | Discretionary |
| Aug 17, 2022 | VTGN | $51.0K | Purchase | 300,000 | $0.17 | Discretionary |